Vivani Medical (VANI) Enterprise Value (2014 - 2026)
Vivani Medical (VANI) posted quarterly Enterprise Value of -$19.7 million for Q1 2026, down 51.82% year-over-year from -$41.0 million in Q1 2025, and down 21.67% quarter-over-quarter from -$16.2 million in Q4 2025.
Vivani Medical (VANI) Enterprise Value (2014 - 2026) Analysis & Trends
Vivani Medical's Enterprise Value history runs 13 years deep, the most recent figure standing at -$19.7 million for Q1 2026.
- In Q1 2026, Enterprise Value fell 51.82% year-over-year to -$19.7 million; the TTM figure through Mar 2026 stood at -$19.7 million (down 51.82% YoY), while the FY2025 annual figure was -$16.2 million, up 11.55% from the prior year.
- Enterprise Value for Q1 2026 stood at -$19.7 million, down from -$16.2 million in the prior quarter.
- The five-year high for Enterprise Value was -$1.3 million in Q4 2023, with the low at -$59.6 million in Q1 2022.
- The 5-year median for Enterprise Value is -$24.8 million (2023), against an average of -$27.1 million.
- The sharpest annual moves came in 2022 and 2023: Enterprise Value plunged 4294.9% in 2022, then soared 97.12% in 2023.
- Vivani Medical's Enterprise Value stood at -$45.1 million in 2022, then jumped by 97.12% to -$1.3 million in 2023, then sank by 1311.69% to -$18.4 million in 2024, then advanced by 11.55% to -$16.2 million in 2025, then slipped by 21.67% to -$19.7 million in 2026.
- Business Quant data shows VANI's Enterprise Value at -$19.7 million in Q1 2026, -$16.2 million in Q4 2025, and -$2.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.83 Bn | 130.98 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 85.79 Bn | 77.79 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 64.95 Bn | 59.77 Bn | 1.37 Bn | -5.18 Bn |
| 4 | Moderna | 58.59 Bn | 53.46 Bn | 52.00 Mn | -5.14 Bn |
| 5 | BeOne Medicines | 41.93 Bn | 36.83 Bn | 1.53 Bn | -5.10 Bn |
| 6 | Alnylam Pharmaceuticals | 31.52 Bn | 28.21 Bn | 992.69 Mn | -3.31 Bn |
| 7 | BioNTech SE | 27.98 Bn | 9.58 Bn | 668.28 Mn | -18.39 Bn |
| 8 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | -1.16 Bn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | 2.12 Bn |
| 10 | Vivani Medical | 121.93 Mn | 102.03 Mn | - | -19.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -19.89 Mn |
| Mar 31, 2026 | -19.75 Mn |
| Dec 31, 2025 | -16.23 Mn |
| Sep 30, 2025 | -2.63 Mn |
| Jun 30, 2025 | -6.79 Mn |
| Mar 31, 2025 | -13.01 Mn |
| Dec 31, 2024 | -18.35 Mn |
| Sep 30, 2024 | -19.65 Mn |
| Jun 30, 2024 | -24.92 Mn |
| Mar 31, 2024 | -29.65 Mn |
| Dec 31, 2023 | -1.30 Mn |
| Sep 30, 2023 | -24.82 Mn |
| Jun 30, 2023 | -32.49 Mn |
| Mar 31, 2023 | -38.07 Mn |
| Dec 31, 2022 | -45.08 Mn |
| Sep 30, 2022 | -51.68 Mn |
| Jun 30, 2022 | -56.38 Mn |
| Mar 31, 2022 | -59.60 Mn |
| Dec 31, 2021 | -2.18 Mn |
| Sep 30, 2021 | -1.18 Mn |